(E)-N~2~-([(4S)-3-(4-Chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazol-1-yl]{[(4-chlorophenyl)sulfonyl]amino}methylene)-L-valinamide

(2S)-2-[(E)-[(4-chlorobenzenesulfonamido)[(4S)-3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazol-1-yl]methylidene]amino]-3-methylbutanamide

(2S)-2-[(E)-[(4-chlorobenzenesulfonamido)[(4S)-3-(4-chlorophenyl)-4-phenyl-4,5-dihydropyrazol-1-yl]methylidene]amino]-3-methylbutanamide

(E)-N~2~-([(4S)-3-(4-Chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazol-1-yl]{[(4-chlorophenyl)sulfonyl]amino}methylene)-L-valinamide

(E)-N~2~-([(4S)-3-(4-Chlorophényl)-4-phényl-4,5-dihydro-1H-pyrazol-1-yl]{[(4-chlorophényl)sulfonyl]amino}méthylène)-L-valinamide

(E)-N~2~-([(4S)-3-(4-Chlorphenyl)-4-phenyl-4,5-dihydro-1H-pyrazol-1-yl]{[(4-chlorphenyl)sulfonyl]amino}methylen)-L-valinamid

1392116-14-1

Butanamide, 2-[[(E)-[(4S)-3-(4-chlorophenyl)-4,5-dihydro-4-phenyl-1H-pyrazol-1-yl][[(4-chlorophenyl)sulfonyl]imino]methyl]amino]-3-methyl-, (2S)-

(1-Phenylpiperidin-4-yl)methanol

(2S)-2-[[[(4S)-5-(4-chlorophenyl)-4-phenyl-3,4-dihydropyrazol-2-yl]-[(4-chlorophenyl)sulfonylamino]methylidene]amino]-3-methylbutanamide

(S)-2-((((S)-3-(4-Chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazol-1-yl)(4-chlorophenylsulfonamido)methylene)amino)-3-methylbutanamide

4-Piperidinemethanol, 1-phenyl-;

Butanamide, 2-((((4S)-3-(4-chlorophenyl)-4,5-dihydro-4-phenyl-1H-pyrazol-1-yl)(((4-chlorophenyl)sulfonyl)amino)methylene)amino)-3-methyl-, (2S)-

Cannabinoid receptor 1

CNR1_HUMAN

CNR1_MOUSE

MFCD30533451